Form D · Biotechnology

BIOVENTRIX, INC.

Mansfield, MA · CIK 0001283259

Offering snapshot reported Oct 8, 2026 · SEC filing

Reported sold
$1.2M
Offering amount: $3M
Investors reported
6
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Sep 29, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 8, 2026Initial$1,200,000No comparison6SEC filing
Sep 9, 2026Amendment$2,965,000$200,000vs Sep 1, 202625SEC filing
Sep 1, 2026Amendment$2,765,000$2,060,000vs Apr 24, 20269SEC filing
Apr 24, 2026Initial$705,000No comparison9SEC filing
Nov 4, 2025Amendment$6,672,600$3,070,600vs Jul 8, 202545SEC filing
Jul 8, 2025Amendment$3,602,000$3,477,000vs Oct 15, 202433SEC filing
Oct 15, 2024Initial$125,000No comparison2SEC filing
Aug 29, 2024Amendment$3,000,000$600,000vs Mar 29, 202421SEC filing
Mar 29, 2024Initial$2,400,000No comparison20SEC filing
Apr 4, 2023Initial$12,650,000No comparison12SEC filing
Jan 25, 2023Initial$1,977,000No comparison18SEC filing
Apr 6, 2022Initial$1,000,000No comparison1SEC filing
Jan 11, 2022Initial$5,978,677No comparison5SEC filing
Aug 10, 2021Amendment$40,755,720No comparisonNot reportedSEC filing
May 6, 2021Amendment$26,061,581No comparisonNot reportedSEC filing
Dec 23, 2020Initial$4,299,000No comparison8SEC filing
Nov 25, 2020Amendment$14,755,700$13,505,700vs Jan 6, 2020108SEC filing
Jan 6, 2020Initial$1,250,000No comparison3SEC filing
Jul 26, 2019Initial$2,549,200No comparison1SEC filing
Jul 23, 2019Amendment$40,000,000$18,221,300vs Apr 30, 2019162SEC filing
Apr 30, 2019Amendment$21,778,700$8,783,300vs Jan 30, 2019158SEC filing
Jan 30, 2019Amendment$12,995,400$1,670,100vs Apr 26, 201855SEC filing
Apr 26, 2018Amendment$11,325,300$8,055,900vs Dec 19, 201749SEC filing
Dec 19, 2017Amendment$3,269,400$1,963,500vs Aug 30, 201739SEC filing
Aug 30, 2017Initial$1,305,900No comparison7SEC filing
Jul 3, 2017Amendment$14,504,967$4,386,000vs Apr 5, 2017152SEC filing
Apr 5, 2017Amendment$10,118,967$2,223,399vs Jan 27, 2017135SEC filing
Jan 27, 2017Amendment$7,895,568$6,693,566vs Aug 1, 2016127SEC filing
Aug 1, 2016Amendment$1,202,002$0vs Jul 26, 201612SEC filing
Jul 26, 2016Initial$1,202,002No comparison12SEC filing
Dec 8, 2015Amendment$14,000,000$5,628,723vs Aug 27, 201564SEC filing
Aug 27, 2015Amendment$8,371,277$6,325,523vs Dec 19, 201464SEC filing
Dec 19, 2014Initial$2,045,754No comparison9SEC filing
Jul 8, 2014Amendment$12,430,879$11,325,931vs Feb 6, 2014195SEC filing
Feb 7, 2014Amendment$1,104,948$0vs Feb 6, 201419SEC filing
Feb 6, 2014Initial$1,104,948No comparison19SEC filing
Jan 24, 2014Amendment$2,000,000$1,000,000vs Dec 13, 20134SEC filing
Dec 13, 2013Initial$1,000,000No comparison2SEC filing
Jul 12, 2013Amendment$6,539,187$6,014,000vs Apr 19, 2013115SEC filing
Apr 19, 2013Initial$525,187No comparison8SEC filing
Jan 28, 2013Amendment$4,500,000$3,732,660vs Nov 21, 2012109SEC filing
Nov 21, 2012Initial$767,340No comparison12SEC filing
Nov 21, 2012Amendment$767,340$0vs Nov 21, 201212SEC filing
May 11, 2012Amendment$5,073,540$2,494,540vs Apr 23, 201288SEC filing
Apr 23, 2012Initial$2,579,000No comparison62SEC filing
Mar 7, 2012Initial$330,000No comparison1SEC filing
Feb 27, 2012Initial$0No comparison0SEC filing
Nov 22, 2011Initial$5,985,817No comparison146SEC filing
Oct 11, 2011Initial$5,052,817No comparison118SEC filing
Oct 11, 2011Initial$5,052,817No comparison118SEC filing
Jul 28, 2011Amendment$3,867,817$565,000vs Feb 28, 201190SEC filing
Feb 28, 2011Amendment$3,302,817$1,592,000vs Jan 26, 201184SEC filing
Jan 26, 2011Amendment$1,710,817$775,000vs Jan 14, 201142SEC filing
Jan 14, 2011Initial$935,817No comparison23SEC filing
Dec 16, 2010Amendment$5,599,505$5,239,505vs Oct 6, 2009157SEC filing
Oct 8, 2010Amendment$4,434,700$4,074,700vs Oct 6, 2009137SEC filing
May 20, 2010Amendment$3,114,000$2,754,000vs Oct 6, 200997SEC filing
Oct 6, 2009Initial$360,000No comparison5SEC filing
Apr 2, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jun 2, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-600544

Source: Form D, filed Oct 8, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
William Abbott Executive
William Abraham Director
Lon Amnest Executive
Lon Annest Executive
Lauren Baker Director
Ori Ben Yehuda Executive
Arthur Bertolero Director
Steven Chartier Director, Executive
Steve Chartier Executive
Bihua Chen Director
Andrew Coats Director
Raymond Cohen Director
James Dillon Director, Executive
George Fazio Director
Gerald Grayson Director
Steven Healy Director
Stephen Healy Director
Andrew Hinson Director
Miller Ken Director, Executive
Noel Messenger Executive
Kenneth Miller Director
Ken Miller Executive
Thaseegaran Pillay, M.D. Executive
Warren Pinckert Director
Warren E. Pinckert, Ii Director
Warren Pinkert Ii Director
Warren E. Pinkert, Ii Director
Rishi Puri Director
Mark Ravich Director
David Richmond Director, Executive
Dave Richmond Director, Executive
Rinda Sama Director
Paul Seid Director
Robert Taglich Director
Michael Taglich Director
Kevin Van Bladel Executive
Kevin Von Bladel Executive
Raphael Wisniewski Director
Christopher Wolff Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
120 Forbes Blvd. Suite 125
Mansfield, MA, 02048